Tanaka Y - Search Results

1

Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study.

Tanaka Y, Takeuchi T, Okada M, Ishii T, Nakajima H, Kawai S, Nagashima T, Hayashi N, Wang L, Tummala R. Tanaka Y, et al. Mod Rheumatol. 2020 Jan;30(1):101-108. doi: 10.1080/14397595.2019.1583833. Epub 2019 Mar 21. Mod Rheumatol. 2020. PMID: 30793642 Clinical Trial.

2

[Successful treatment of intravenous cyclophosphamide pulse therapy for systemic lupus erythematosus complicated with steroid-resistant hemolytic anemia].

Tokunaga M, Saito K, Nakatsuka K, Nakayamada S, Nakano K, Tsujimura S, Ota T, Tanaka Y. Tokunaga M, et al. Among authors: tanaka y. Nihon Rinsho Meneki Gakkai Kaishi. 2003 Oct;26(5):304-9. doi: 10.2177/jsci.26.304. Nihon Rinsho Meneki Gakkai Kaishi. 2003. PMID: 14635405 Japanese.

3

Overcoming treatment unresponsiveness mediated by P-glycoprotein overexpression on lymphocytes in refractory active systemic lupus erythematosus.

Tsujimura S, Saito K, Tokunaga M, Nakatsuka K, Nakayamada S, Nakano K, Tanaka Y. Tsujimura S, et al. Among authors: tanaka y. Mod Rheumatol. 2005;15(1):28-32. doi: 10.1007/s10165-004-0354-x. Mod Rheumatol. 2005. PMID: 17028818

4

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM).

Yamanaka H, Tanaka Y, Sekiguchi N, Inoue E, Saito K, Kameda H, Iikuni N, Nawata M, Amano K, Shinozaki M, Takeuchi T. Yamanaka H, et al. Among authors: tanaka y. Mod Rheumatol. 2007;17(1):28-32. doi: 10.1007/s10165-006-0532-0. Epub 2007 Feb 20. Mod Rheumatol. 2007. PMID: 17278019

5

A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.

Tanaka Y, Yamamoto K, Takeuchi T, Nishimoto N, Miyasaka N, Sumida T, Shima Y, Takada K, Matsumoto I, Saito K, Koike T. Tanaka Y, et al. Mod Rheumatol. 2007;17(3):191-7. doi: 10.1007/s10165-007-0565-z. Epub 2007 Jun 20. Mod Rheumatol. 2007. PMID: 17564773 Clinical Trial.

6

Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.

Nakayamada S, Saito K, Umehara H, Ogawa N, Sumida T, Ito S, Minota S, Nara H, Kondo H, Okada J, Mimori T, Yoshifuji H, Sano H, Hashimoto N, Sugai S, Tanaka Y. Nakayamada S, et al. Among authors: tanaka y. Mod Rheumatol. 2007;17(6):464-9. doi: 10.1007/s10165-007-0627-2. Epub 2007 Dec 20. Mod Rheumatol. 2007. PMID: 18084697 Clinical Trial.

7

Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis.

Eguchi K, Saito K, Kondo M, Hidaka T, Ueki Y, Tanaka Y; LCAP Investigators in Kyushu College of Rheumatology (LIKCR). Eguchi K, et al. Among authors: tanaka y. Mod Rheumatol. 2007;17(6):481-5. doi: 10.1007/s10165-007-0630-7. Epub 2007 Dec 20. Mod Rheumatol. 2007. PMID: 18084700 Clinical Trial.

8

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2).

Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, Nawata M, Kameda H, Iwata S, Amano K, Yamanaka H. Tanaka Y, et al. Mod Rheumatol. 2008;18(2):146-52. doi: 10.1007/s10165-008-0026-3. Epub 2008 Feb 19. Mod Rheumatol. 2008. PMID: 18283523 Free PMC article.

9

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).

Takeuchi T, Yamanaka H, Inoue E, Nagasawa H, Nawata M, Ikari K, Saito K, Sekiguchi N, Sato E, Kameda H, Iwata S, Mochizuki T, Amano K, Tanaka Y. Takeuchi T, et al. Among authors: tanaka y. Mod Rheumatol. 2008;18(5):447-54. doi: 10.1007/s10165-008-0077-5. Epub 2008 May 21. Mod Rheumatol. 2008. PMID: 18493716

10

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.

Nawata M, Saito K, Nakayamada S, Tanaka Y. Nawata M, et al. Among authors: tanaka y. Mod Rheumatol. 2008;18(5):460-4. doi: 10.1007/s10165-008-0089-1. Epub 2008 Jun 6. Mod Rheumatol. 2008. PMID: 18535759 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,356 results

Search Page

Filters